Literature DB >> 19038507

[HLA polymorphism and Behçet's disease in Moroccan population].

N Bennani1, O Atouf, N Benseffaj, C Brick, M Essakalli.   

Abstract

OBJECTIVES: We have study the various associations between Behçet disease and alleles HLA class I and II in Moroccan population. The distribution of HLA alleles involved in the disease is assessed according to clinical signs and sex. PATIENTS AND METHODS: Patients suffering from Behçet's disease have been compared to healthy controls matched by age and ethnic origin. The HLA typing has been conducted by using microlymphocytotoxicity for the class I (A and B) and molecular biology (polymerase chain reaction-sequence specific primers) for the class II (DR and DQ).
RESULTS: In addition to the allele B51, -A2, -B5102, -B58 and -B72 predispose to the Behçet's disease and the alleles A23, -A33, -B18, -B41 and -B49 have a negative correlation in our Moroccan patients. The alleles A2 and -B72 are specific to men, -A68 and -B58 to women, whereas -B51 and -B5102 are predisposing to the Behçet's disease of both genders. The allele B51 is related to the mucous manifestations, -B72 to the vascularitis manifestations and -B58 to the cutaneous manifestations. The haplotypes A2-B51 has a high positive correlation with this Behçet's disease. Concerning class II, none of the alleles DRB1* is implicated in the pathology even though the allele DQB1*02 ensures the patients' protection.
CONCLUSIONS: The allele HLA-B51 shows a high positive correlation with the Behçet's disease. Other genetic factors seem to be implicated in susceptibility or protection against the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038507     DOI: 10.1016/j.patbio.2008.09.012

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

1.  Association of HLA Alleles with Primary Sjögren Syndrome in the South Tunisian Population.

Authors:  Aida Charfi; Nadia Mahfoudh; Arwa Kamoun; Feten Frikha; Chifa Dammak; Lilia Gaddour; Feiza Hakim; Leila Maalej; Bakhta Mallek; Ines Kammoun; Zouhir Bahloul; Hafedh Makni
Journal:  Med Princ Pract       Date:  2019-07-05       Impact factor: 1.927

Review 2.  Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and Management.

Authors:  Anthony Nguyen; Shubhra Upadhyay; Muhammad Ali Javaid; Abdul Moiz Qureshi; Shahan Haseeb; Nismat Javed; Christopher Cormier; Asif Farooq; Abu Baker Sheikh
Journal:  Inflamm Intest Dis       Date:  2021-11-04

3.  Behçet's Disease: Pulmonary Aneurysm Resolution with Oral Therapy and HLA B72 Allele Association.

Authors:  Clarissa de Albuquerque Botura; Luiz Eduardo Bersani-Amado; Antônio Rubens Zacarias-Júnior; Sueli Donizete Boreli; Naiene Gomes Gordo Stecca; Bruno Ambrósio da Rocha; Roberto Kenji Nakamura Cuman; Ciomar Aparecida Bersani-Amado
Journal:  Clin Med Res       Date:  2018-04-02

4.  Behçet disease, new insights in disease associations and manifestations: a next-generation sequencing study.

Authors:  M Elfishawi; G Mossallam; D G Augusto; G Montero-Martin; H de Bruin; L Van de Pasch; P J Norman; E Rozemuller; M Fernandez-Vina; A Abrudescu; J A Hollenbach; K Zaky; S Elfishawi
Journal:  Clin Exp Immunol       Date:  2021-02-03       Impact factor: 5.732

5.  Birmingham Behçet's service: classification of disease and application of the 2014 International Criteria for Behçet's Disease (ICBD) to a UK cohort.

Authors:  Tim Blake; Luke Pickup; David Carruthers; Erika Marie Damato; Alastair Denniston; John Hamburger; Claire Maxton; Debbie Mitton; Philip I Murray; Peter Nightingale; Ana Poveda-Gallego; Andrea Richards; Andrew Whallett; Deva Situnayake
Journal:  BMC Musculoskelet Disord       Date:  2017-03-11       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.